KMDA Q2 2020 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$495M

Q2 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$33M-6.1% YoY

Gross Profit

$11M33.6% margin

Operating Income

$4M12.0% margin

Net Income

$3M10.5% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

-0.6%

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$10M

Stock-Based Comp.

$330,000

Balance Sheet

Total Assets

$206M

Total Liabilities

$36M

Stockholders' Equity

$170M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$35M	-6.1%
Gross Profit	$11M	$14M	-18.3%
Operating Income	$4M	$6M	-37.8%
Net Income	$3M	$6M	-43.7%